vs

Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and Envista Holdings Corp (NVST). Click either name above to swap in a different company.

ILLUMINA, INC. is the larger business by last-quarter revenue ($1.1B vs $750.6M, roughly 1.5× Envista Holdings Corp). ILLUMINA, INC. runs the higher net margin — 12.3% vs 4.4%, a 7.9% gap on every dollar of revenue. On growth, Envista Holdings Corp posted the faster year-over-year revenue change (15.0% vs 4.8%). ILLUMINA, INC. produced more free cash flow last quarter ($251.0M vs $91.7M). Over the past eight quarters, Envista Holdings Corp's revenue compounded faster (9.7% CAGR vs -1.3%).

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

Envista Forensics is a United States based company that provides forensic engineering and recovery solutions for the insurance, legal, and risk management industries in the United States and internationally. Originally LWG Consulting, Inc., The company rebranded itself as Envista Forensics in 2017.

ILMN vs NVST — Head-to-Head

Bigger by revenue
ILMN
ILMN
1.5× larger
ILMN
$1.1B
$750.6M
NVST
Growing faster (revenue YoY)
NVST
NVST
+10.2% gap
NVST
15.0%
4.8%
ILMN
Higher net margin
ILMN
ILMN
7.9% more per $
ILMN
12.3%
4.4%
NVST
More free cash flow
ILMN
ILMN
$159.3M more FCF
ILMN
$251.0M
$91.7M
NVST
Faster 2-yr revenue CAGR
NVST
NVST
Annualised
NVST
9.7%
-1.3%
ILMN

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
ILMN
ILMN
NVST
NVST
Revenue
$1.1B
$750.6M
Net Profit
$134.0M
$32.9M
Gross Margin
66.1%
54.7%
Operating Margin
19.2%
9.8%
Net Margin
12.3%
4.4%
Revenue YoY
4.8%
15.0%
Net Profit YoY
2641.7%
EPS (diluted)
$0.87
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILMN
ILMN
NVST
NVST
Q1 26
$1.1B
Q4 25
$1.2B
$750.6M
Q3 25
$669.9M
Q2 25
$682.1M
Q1 25
$616.9M
Q4 24
$1.1B
$652.9M
Q3 24
$1.1B
$601.0M
Q2 24
$1.1B
$633.1M
Net Profit
ILMN
ILMN
NVST
NVST
Q1 26
$134.0M
Q4 25
$334.0M
$32.9M
Q3 25
$-30.3M
Q2 25
$26.4M
Q1 25
$18.0M
Q4 24
$186.0M
$1.2M
Q3 24
$705.0M
$8.2M
Q2 24
$-2.0B
$-1.2B
Gross Margin
ILMN
ILMN
NVST
NVST
Q1 26
66.1%
Q4 25
65.5%
54.7%
Q3 25
55.3%
Q2 25
54.2%
Q1 25
54.5%
Q4 24
65.9%
57.1%
Q3 24
69.0%
52.8%
Q2 24
64.8%
51.6%
Operating Margin
ILMN
ILMN
NVST
NVST
Q1 26
19.2%
Q4 25
17.4%
9.8%
Q3 25
8.6%
Q2 25
6.8%
Q1 25
6.3%
Q4 24
15.8%
7.1%
Q3 24
68.6%
3.5%
Q2 24
-147.2%
-182.2%
Net Margin
ILMN
ILMN
NVST
NVST
Q1 26
12.3%
Q4 25
28.8%
4.4%
Q3 25
-4.5%
Q2 25
3.9%
Q1 25
2.9%
Q4 24
16.8%
0.2%
Q3 24
65.3%
1.4%
Q2 24
-178.8%
-181.9%
EPS (diluted)
ILMN
ILMN
NVST
NVST
Q1 26
$0.87
Q4 25
$2.16
$0.20
Q3 25
$-0.18
Q2 25
$0.16
Q1 25
$0.10
Q4 24
$1.16
$0.00
Q3 24
$4.42
$0.05
Q2 24
$-12.48
$-6.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILMN
ILMN
NVST
NVST
Cash + ST InvestmentsLiquidity on hand
$1.2B
$1.2B
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$2.7B
$3.1B
Total Assets
$6.6B
$5.7B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILMN
ILMN
NVST
NVST
Q1 26
$1.2B
Q4 25
$1.6B
$1.2B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$93.0M
$1.1B
Q3 24
$70.0M
$991.3M
Q2 24
$74.0M
$1.0B
Total Debt
ILMN
ILMN
NVST
NVST
Q1 26
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.5B
Stockholders' Equity
ILMN
ILMN
NVST
NVST
Q1 26
$2.7B
Q4 25
$2.7B
$3.1B
Q3 25
$3.1B
Q2 25
$3.1B
Q1 25
$3.0B
Q4 24
$2.4B
$2.9B
Q3 24
$2.1B
$3.1B
Q2 24
$1.4B
$3.0B
Total Assets
ILMN
ILMN
NVST
NVST
Q1 26
$6.6B
Q4 25
$6.6B
$5.7B
Q3 25
$5.6B
Q2 25
$5.7B
Q1 25
$5.5B
Q4 24
$6.3B
$5.4B
Q3 24
$6.0B
$5.5B
Q2 24
$6.1B
$5.4B
Debt / Equity
ILMN
ILMN
NVST
NVST
Q1 26
Q4 25
0.47×
Q3 25
0.47×
Q2 25
0.46×
Q1 25
0.47×
Q4 24
0.48×
Q3 24
0.46×
Q2 24
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILMN
ILMN
NVST
NVST
Operating Cash FlowLast quarter
$289.0M
$108.0M
Free Cash FlowOCF − Capex
$251.0M
$91.7M
FCF MarginFCF / Revenue
23.0%
12.2%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
2.16×
3.28×
TTM Free Cash FlowTrailing 4 quarters
$1.1B
$230.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILMN
ILMN
NVST
NVST
Q1 26
$289.0M
Q4 25
$321.0M
$108.0M
Q3 25
$78.7M
Q2 25
$88.7M
Q1 25
$300.0K
Q4 24
$364.0M
$132.4M
Q3 24
$316.0M
$70.7M
Q2 24
$80.0M
$93.1M
Free Cash Flow
ILMN
ILMN
NVST
NVST
Q1 26
$251.0M
Q4 25
$267.0M
$91.7M
Q3 25
$67.9M
Q2 25
$76.4M
Q1 25
$-5.6M
Q4 24
$335.0M
$123.8M
Q3 24
$284.0M
$63.3M
Q2 24
$49.0M
$86.3M
FCF Margin
ILMN
ILMN
NVST
NVST
Q1 26
23.0%
Q4 25
23.0%
12.2%
Q3 25
10.1%
Q2 25
11.2%
Q1 25
-0.9%
Q4 24
30.3%
19.0%
Q3 24
26.3%
10.5%
Q2 24
4.4%
13.6%
Capex Intensity
ILMN
ILMN
NVST
NVST
Q1 26
Q4 25
2.2%
Q3 25
1.6%
Q2 25
1.8%
Q1 25
1.0%
Q4 24
2.6%
1.3%
Q3 24
3.0%
1.2%
Q2 24
2.8%
1.1%
Cash Conversion
ILMN
ILMN
NVST
NVST
Q1 26
2.16×
Q4 25
0.96×
3.28×
Q3 25
Q2 25
3.36×
Q1 25
0.02×
Q4 24
1.96×
110.33×
Q3 24
0.45×
8.62×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILMN
ILMN

Product revenue$917.0M84%
Service and other revenue$174.0M16%

NVST
NVST

Other$375.8M50%
Specialty Productsand Technologies$188.4M25%
Equipmentand Consumables$186.4M25%

Related Comparisons